Dubai, UAE: His Excellency Humaid Al Qutami, Director General of the Dubai Health Authority (DHA) inaugurated MEDLAB, one of the region’s most prominent medical laboratory exhibitions at the Dubai World Trade Centre on Monday.

Helal Al Marri, Director General of Dubai’s Department of Tourism and Commerce Marketing accompanied Al Qutami, along with other officials.

Al Qutami said Dubai has become the preferred destination for international congresses and exhibitions, especially in the field of health, due to its unique position in the international market and advanced capabilities, which guarantees their success.

He added that Medlab represents an important opportunity for specialists in the field to learn about all the technologies and smart solutions in medical laboratories.

 He pointed out that the diagnostic laboratory services play a major role in the health care system of all countries, especially with the advancement of equipment and technology, which greatly contribute to the development of preventive health programmes and initiatives.

Focusing on the core lab and specialist lab units, the congress this year is led by a strong scientific committee, ensuring that current issues and innovation are at the centre of all programmes. 

The event will take place at the Dubai World Trade Centre from February 4 to 7. The 18th edition of the MEDLAB Congress will host a selection of multi-disciplinary sessions in laboratory medicine that will provide exceptional education as well as management solutions to help medical lab professionals advance their skills and improve service & care in the region.

The congress will focus on the implementation of quick and safe selection, performance and evaluation of results of new and established laboratory tests, the congress is a learning and sharing platform for all laboratory workers to advance professionally and develop adaptive solutions for daily practice in the lab.

-Ends-

For further information, please contact:

Mahmoud Al Ali

Head of Media

Dubai Health Authority

myalali@dha.gov.ae 

+9714 219 7260

Kamakshi Gupta and Noor Nazzal

Communications Analysts- Media Dept.

Dubai Health Authority

klgupta@dha.gov.ae nnnazzal@dha.gov.ae 

+9714 2197455

About the Dubai Health Authority:

The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. 

Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.

In May 2018, H.H Sheikh Mohammed, issued Law No. (6) Of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.

According to the Law, DHA will ensure the availability of quality medical insurance programmes, improve medical services according to the highest international standards, contribute to providing attractive infrastructure for investments, boost Dubai’s position as a global hub for medical tourism and medical education, encourage innovation in the healthcare sector and improve preventive healthcare measures.

The Law specified DHA’s responsibilities to include preparing a comprehensive strategic plan for Dubai’s healthcare sector, conducting studies and surveys to define Dubai’s future needs and matching the results with future investments, licensing and monitoring medical workers and medical facilities according to DHA’s approved regulations. Its responsibilities also include regulating medical education and medical research in collaboration with competent local and international authorities and drafting and developing policies and procedures for the healthcare sector in Dubai.

The Law authorises DHA to regulate and approve the prices of medical services offered by private healthcare facilities in Dubai and ensure the quality of medical services. DHA is also responsible for regulating and facilitating the sending of patients for specialised medical treatment to healthcare facilities both within and outside the country, regulating and overseeing medical tourism in collaboration with concerned authorities, managing and developing policies that govern medical insurance and regulating medical advertising in Dubai.

H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.

Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.

In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.

For more information, visit DHA’s website: www.dha.gov.ae 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.